Tech Company M&A Transactions
Myrexis Acquisition
Myrexis, based in New York, was bought by Deltek. The financial terms of the deal were not announced.
Transaction Overview
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
600 5th Ave. 2nd Floor
New York, NY 10020
USA
New York, NY 10020
USA
Phone
Website
Email Address
Overview
Myrexis, Inc. (OTC: MYRX, formerly Myriad Pharmaceuticals) was a fully integrated biotechnology company discovering, developing and commercializing first-in-class/best-in-class products for the treatment of diseases with high unmet need such as cancer and HIV infection. In February 2012, Myrexis announced that it was shifting its strategic direction and suspended development activities of all its preclinical and clinical development programs in oncology and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Couchman
Browse more venture capital transactions:
Prev: 12/15/2009: Fat Spaniel Technologies venture capital transaction
Next: 12/15/2009: AlikeList venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs